Losing Weight for Less $$$ & You Can’t Pay People to Have Kids
Publisher |
Morning Brew
Media Type |
audio
Podknife tags |
Business
Business News
Interview
Categories Via RSS |
Business
Business News
News
Publication Date |
Aug 28, 2024
Episode Duration |
00:29:41
Episode 397: Neal and Toby discuss Eli Lilly’s newest form of Zepbound, their blockbuster weight-loss drug that is half the price of its predecessor. Will this eliminate the competition? Then, Mark Zuckerberg writes a letter expressing his regret for demoting Covid-19 content during the pandemic as it felt ‘pressured’ from the Biden administration. Next, the Kelce brothers just scored a massive $100M deal with Amazon to take their podcast to… new heights. Meanwhile, birth rates around the world are falling and some countries are trying to pay people to start families, and it’s not working. Also, dinner sausages are becoming more and more popular as price-conscious shoppers shift to cheaper meats. Lastly, brutal heat waves sweeping across the country are forcing outdoor workers to wear high-tech cooling systems to survive.  Visit https://www.massmutual.com/ for all your financial planning needs Get your Morning Brew Daily T-Shirt HERE: https://shop.morningbrew.com/products/morning-brew-radio-t-shirt?_pos=1&_sid=6b0bc409d&_ss=r&variant=45353879044316  Listen to Morning Brew Daily Here: https://link.chtbl.com/MBD Watch Morning Brew Daily Here: https://www.youtube.com/@MorningBrewDailyShow Listen to Money with Katie's podcast on "The Messy Economic Truth that the "Birth Rate Panic" Reveals" Here 00:00 - Shirts at the US Open 02:40 - Eli Lilly Cutting Prices  06:30 - Zuck Covid Content Regrets  09:45 - Kelce Mega Podcast Deal 16:00 - South Korean Birth Rate 20:00 - Sausage Impact on the Economy 23:20 - Ice Pack Work Vests Learn more about your ad choices. Visit megaphone.fm/adchoices

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review